The Harvard research funding crisis has triggered significant disruption within the university’s esteemed research teams, particularly at the Wyss Institute, where Don Ingber leads groundbreaking projects.As the federal government imposed a stop-work order following Harvard’s refusal to comply with controversial demands from the Trump administration, vital initiatives, including innovative organ-on-a-chip technologies, have faced an uncertain future.